Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 12/03/2026
In
Objective
To achieve a high level of capital growth by investing worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector.
AIC sector
Management group
Company website
Launch date
28/04/1995
March
Domicile
United Kingdom
Fund manager
Sven H. Borho, Trevor M. Polischuk
Dividend frequency
Semi-Annually
Wind-up provisions
Shareholders have approve the continuance of the Company as an investment trust for a further period of five years. Continuation vote at every fifth AGM, the next of which will be in 2029.
Continuation vote
5 yearly
| Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|
| 1,272.08 | 1,374.41 | 339.50 | 364.67 | -6.90 | 0 | 0.71 | Jun, Nov | 0.8 (31/03/2025) |
Scroll
Dividends
Dividends declared in last 12 months
| Ex-dividend date | Payment date | Dividend amount | Special dividend | Financial year |
|---|---|---|---|---|
| 27/11/2025 | 09/01/2026 | 0.700 | No | 2026 |
| 12/06/2025 | 23/07/2025 | 1.700 | No | 2025 |
Scroll
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Worldwide Healthcare Trust | Share price total return | 15.8 | 14.9 | -1.5 | 119.7 |
| Biotechnology & Healthcare AIC sector | Share price total return | 19.6 | 5.8 | -17.7 | 93.2 |
Scroll
Share structure
Number of shares
374,692,417
226,972,783
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 899,738 | 27,988,990 | 396,087,475 | 1,549,596,305 |
| Average | N/A | 1,399,450 | 1,565,560 | 1,228,860 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 3.05 | 98.77 | 1,296.51 | 5,116.06 |
| Average | N/A | 4.94 | 5.12 | 4.06 |
Scroll
Trading details
| ISIN | Ticker | Traded currency | Stock exchange |
|---|---|---|---|
| GB00BN455J50 | WWH | GBX | London Stock Exchange - MAIN Boerse Berlin Chi-x Europe Limited London Stock Exchange Pink Sheets Llc (nqb) |
Scroll
Top holdings
Data as at : 30/11/2025
| Investment | % of total assets |
|---|---|
| Eli Lilly and Co | 13.2 |
| Boston Scientific Corp | 9.1 |
| AstraZeneca PLC | 8.4 |
| Intuitive Surgical Inc | 6.2 |
| Edwards Lifesciences Corp | 5.5 |
| argenx SE ADR | 4.8 |
| Stryker Corp | 4.6 |
| Alnylam Pharmaceuticals Inc | 3.7 |
| Daiichi Sankyo Co Ltd | 2.8 |
| Natera Inc | 2.8 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
